Literature DB >> 19796938

5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.

David A Ellis1, Julie K Blazel, Chinh V Tran, Frank Ruebsam, Douglas E Murphy, Lian-Sheng Li, Jingjing Zhao, Yuefen Zhou, Helen M McGuire, Alan X Xiang, Stephen E Webber, Qiang Zhao, Qing Han, Charles R Kissinger, Matthew Lardy, Alberto Gobbi, Richard E Showalter, Amit M Shah, Mei Tsan, Rupal A Patel, Laurie A LeBrun, Ruhi Kamran, Darian M Bartkowski, Thomas G Nolan, Daniel A Norris, Maria V Sergeeva, Leo Kirkovsky.   

Abstract

The discovery of 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of the HCV RNA-dependent RNA polymerase (NS5B) is described. Several of these agents also display potent antiviral activity in cell culture experiments (EC50 <0.10 microM). In vitro DMPK data for selected compounds as well as crystal structures of representative inhibitors complexed with the NS5B protein are also disclosed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796938     DOI: 10.1016/j.bmcl.2009.09.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis.

Authors:  Déborah Harrus; Neveen Ahmed-El-Sayed; Philip C Simister; Steve Miller; Martine Triconnet; Curt H Hagedorn; Kathleen Mahias; Félix A Rey; Thérèse Astier-Gin; Stéphane Bressanelli
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors.

Authors:  Sarah E Boyce; Neeraj Tirunagari; Anita Niedziela-Majka; Jason Perry; Melanie Wong; Elaine Kan; Leanna Lagpacan; Ona Barauskas; Magdeleine Hung; Martijn Fenaux; Todd Appleby; William J Watkins; Uli Schmitz; Roman Sakowicz
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.